Abstract

Genital herpes is a venereal disease caused by herpes simplex virus (HSV). Although HSV symptoms can be reduced with antiviral drugs, there is no cure. Moreover, because HSV infected individuals are often unaware of their infection, it is highly likely that they will transmit HSV to their sexual partner. Once infected, an individual has to live with HSV for their entire life, and HSV infection can lead to meningitis, encephalitis, and neonatal herpes as a result of vertical transmission. In addition, HSV infection increases the rates of human immunodeficiency virus (HIV) infection and transmission. Because of the high burden of genital herpes, HSV vaccines have been developed, but none have been very successful. In this review, we discuss the current status of genital herpes vaccine development.

Highlights

  • Genital herpes is a common sexually transmitted disease (STD) caused by the herpes simplex virus (HSV)

  • There is no clear treatment for genital herpes because during a portion of its lifecycle HSV is dormant in the ganglia, and anti-HSV drugs are only effective during active virus shedding [1,2,3]

  • Genital herpes can be caused by both HSV-1 and HSV-2

Read more

Summary

Introduction

Genital herpes is a common sexually transmitted disease (STD) caused by the herpes simplex virus (HSV). Genital herpes can be caused by both HSV-1 and HSV-2. Genital herpes can occur at all ages, can be painful, and may lead to multiple complications, including meningitis, encephalitis, and vertical infections from mother to fetus. Infection with HSV significantly increases the risk of human immunodeficiency virus (HIV) infection. Vaccines 2020, 8, x immune response in the genital tract, which leads to more CD4 T cells that express the CCR5 receptor, which is involved in HIV transmission infection. Effective vaccine development is necessary to cope with genital herpes infection status [17]. As well as the limitations and prospects in this and related fields

The HSV Life Cycle
The Anti-HSV IMMUNE Response
Overview
Recent Progress
Limitations & Future
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.